Cargando…
Long-Term Survival After Intravenous Thrombolysis for Ischemic Stroke: A Propensity Score-Matched Cohort With up to 10-Year Follow-Up
BACKGROUND AND PURPOSE—: Intravenous thrombolysis with alteplase is one of the few approved treatments for acute ischemic stroke; nevertheless, little is known about its long-term effects on survival and recovery because clinical trials follow-up times are limited. METHODS—: Patients registered betw...
Autores principales: | Muruet, Walter, Rudd, Anthony, Wolfe, Charles D.A., Douiri, Abdel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839705/ https://www.ncbi.nlm.nih.gov/pubmed/29440582 http://dx.doi.org/10.1161/STROKEAHA.117.019889 |
Ejemplares similares
-
Risk and Secondary Prevention of Stroke Recurrence: A Population-Base Cohort Study
por: Flach, Clare, et al.
Publicado: (2020) -
Stroke Care in the United Kingdom During the COVID-19 Pandemic
por: Douiri, Abdel, et al.
Publicado: (2021) -
Short- and long-term mortality after intravenous thrombolysis for acute ischemic stroke: A propensity score-matched cohort with 5-year follow-up
por: Heo, Nam Hun, et al.
Publicado: (2021) -
Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
por: Selvik, Henriette Aurora, et al.
Publicado: (2018) -
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017)